Sign Up
bg
A

Allogene (ALLO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

  • USD1.36
  • USD1.43
  • USD1.31
  • USD3.78
  • 18.30%
  • --
  • 2.77M
  • 2.47M
  • 276M
  • 0.86
  • -43.70%

Stock News